232 related articles for article (PubMed ID: 21426023)
1. Examining the basis of isoniazid tolerance in nonreplicating Mycobacterium tuberculosis using transcriptional profiling.
Tudó G; Laing K; Mitchison DA; Butcher PD; Waddell SJ
Future Med Chem; 2010 Aug; 2(8):1371-83. PubMed ID: 21426023
[TBL] [Abstract][Full Text] [Related]
2. Differential Isoniazid Response Pattern Between Active and Dormant
Abo-Kadoum MA; Dai Y; Asaad M; Hamdi I; Xie J
Microb Drug Resist; 2021 Jun; 27(6):768-775. PubMed ID: 33211637
[TBL] [Abstract][Full Text] [Related]
3. Isoniazid induces its own resistance in nonreplicating Mycobacterium tuberculosis.
Siddiqi S; Takhar P; Baldeviano C; Glover W; Zhang Y
Antimicrob Agents Chemother; 2007 Jun; 51(6):2100-4. PubMed ID: 17438054
[TBL] [Abstract][Full Text] [Related]
4. The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol.
Colangeli R; Helb D; Sridharan S; Sun J; Varma-Basil M; Hazbón MH; Harbacheuski R; Megjugorac NJ; Jacobs WR; Holzenburg A; Sacchettini JC; Alland D
Mol Microbiol; 2005 Mar; 55(6):1829-40. PubMed ID: 15752203
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterium tuberculosis Is Resistant to Isoniazid at a Slow Growth Rate by Single Nucleotide Polymorphisms in katG Codon Ser315.
Jeeves RE; Marriott AA; Pullan ST; Hatch KA; Allnutt JC; Freire-Martin I; Hendon-Dunn CL; Watson R; Witney AA; Tyler RH; Arnold C; Marsh PD; McHugh TD; Bacon J
PLoS One; 2015; 10(9):e0138253. PubMed ID: 26382066
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional Adaptation of Drug-tolerant Mycobacterium tuberculosis During Treatment of Human Tuberculosis.
Walter ND; Dolganov GM; Garcia BJ; Worodria W; Andama A; Musisi E; Ayakaka I; Van TT; Voskuil MI; de Jong BC; Davidson RM; Fingerlin TE; Kechris K; Palmer C; Nahid P; Daley CL; Geraci M; Huang L; Cattamanchi A; Strong M; Schoolnik GK; Davis JL
J Infect Dis; 2015 Sep; 212(6):990-8. PubMed ID: 25762787
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of isoniazid killing: clarity through the scope of genetics.
Vilchèze C; Jacobs WR
Annu Rev Microbiol; 2007; 61():35-50. PubMed ID: 18035606
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanism of the synergistic activity of ethambutol and isoniazid against
Zhu C; Liu Y; Hu L; Yang M; He ZG
J Biol Chem; 2018 Oct; 293(43):16741-16750. PubMed ID: 30185616
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of katG expression is associated with isoniazid resistance in Mycobacterium tuberculosis.
Ando H; Kitao T; Miyoshi-Akiyama T; Kato S; Mori T; Kirikae T
Mol Microbiol; 2011 Mar; 79(6):1615-28. PubMed ID: 21244531
[TBL] [Abstract][Full Text] [Related]
10. Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis.
Unissa AN; Subbian S; Hanna LE; Selvakumar N
Infect Genet Evol; 2016 Nov; 45():474-492. PubMed ID: 27612406
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulator-induced phenotype screen reveals drug potentiators in Mycobacterium tuberculosis.
Ma S; Morrison R; Hobbs SJ; Soni V; Farrow-Johnson J; Frando A; Fleck N; Grundner C; Rhee KY; Rustad TR; Sherman DR
Nat Microbiol; 2021 Jan; 6(1):44-50. PubMed ID: 33199862
[TBL] [Abstract][Full Text] [Related]
12. The effect of growth rate on pyrazinamide activity in Mycobacterium tuberculosis - insights for early bactericidal activity?
Pullan ST; Allnutt JC; Devine R; Hatch KA; Jeeves RE; Hendon-Dunn CL; Marsh PD; Bacon J
BMC Infect Dis; 2016 May; 16():205. PubMed ID: 27184366
[TBL] [Abstract][Full Text] [Related]
13. Comparing isogenic strains of Beijing genotype Mycobacterium tuberculosis after acquisition of Isoniazid resistance: A proteomics approach.
Nieto R LM; Mehaffy C; Dobos KM
Proteomics; 2016 May; 16(9):1376-80. PubMed ID: 26929115
[TBL] [Abstract][Full Text] [Related]
14. The genetics and biochemistry of isoniazid resistance in mycobacterium tuberculosis.
Slayden RA; Barry CE
Microbes Infect; 2000 May; 2(6):659-69. PubMed ID: 10884617
[TBL] [Abstract][Full Text] [Related]
15. Mycobacterium tuberculosis persistence mutants identified by screening in isoniazid-treated mice.
Dhar N; McKinney JD
Proc Natl Acad Sci U S A; 2010 Jul; 107(27):12275-80. PubMed ID: 20566858
[TBL] [Abstract][Full Text] [Related]
16. OxiR specifically responds to isoniazid and regulates isoniazid susceptibility in mycobacteria.
Yang M; Zhang L; Tao HL; Sun YC; Lou ZZ; Jia WZ; Hu LH; Gao CH
FEMS Microbiol Lett; 2019 May; 366(10):. PubMed ID: 31125044
[TBL] [Abstract][Full Text] [Related]
17. Dormant Mycobacterium tuberculosis converts isoniazid to the active drug in a Wayne's model of dormancy.
Raghunandanan S; Jose L; Kumar RA
J Antibiot (Tokyo); 2018 Nov; 71(11):939-949. PubMed ID: 30185901
[TBL] [Abstract][Full Text] [Related]
18. RbpA and σ
Wang Z; Cumming BM; Mao C; Zhu Y; Lu P; Steyn AJC; Chen S; Hu Y
Mol Microbiol; 2018 Jun; 108(6):627-640. PubMed ID: 29575247
[TBL] [Abstract][Full Text] [Related]
19. Quantitative-competitive polymerase chain reaction for rapid susceptibility testing of Mycobacterium tuberculosis to isoniazid.
Afghani B; Stutman HR
Biochem Mol Med; 1997 Apr; 60(2):182-6. PubMed ID: 9169101
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of isoniazid-regulated genes in drug-treated dormant Mycobacterium tuberculosis.
Karakousis PC; Williams EP; Bishai WR
J Antimicrob Chemother; 2008 Feb; 61(2):323-31. PubMed ID: 18156607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
